How to Get Zepbound

Who Qualifies for Zepbound

The label defines two doors. The first is chronic weight management: adults with a BMI of 30 or higher, or 27 and above with at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol. The second is obstructive sleep apnea in adults with obesity — an indication that matters far beyond the clinic, because it opens coverage pathways that pure weight loss does not, including for Medicare patients, where weight loss alone is excluded but the sleep apnea indication can qualify.

Providers also screen for contraindications — personal or family history of medullary thyroid carcinoma and a handful of other conditions — before prescribing. Treatment is a once-weekly injection with gradual dose titration over several months. If you want a quick read on whether you clear the baseline criteria, the eligibility assessment takes about two minutes and frames the conversation with any prescriber.

The Three Prescription Routes

Your own doctor is the right route if you have an established relationship and comorbidities that deserve in-person management — sleep apnea evaluation in particular often involves a sleep study your physician coordinates. Telehealth is the speed route: intake, provider review within 24 to 72 hours, video visit where your state requires it, and a prescription sent to your chosen fulfillment channel. Weight management clinics add in-person monitoring, body composition tracking, and higher-touch titration support at a higher service cost.

All three produce the same thing — a valid Zepbound prescription — so choose on logistics: speed and convenience favor telehealth, complexity favors your physician, accountability preferences favor a clinic. The channel comparison across all GLP-1 access is detailed in telehealth vs clinic vs pharmacy.

LillyDirect Vials: The Self-Pay Game Changer

Zepbound lists around $1,086 per month, but Eli Lilly sells single-dose vials directly through its LillyDirect channel at $349 per month for the 2.5 mg dose and $499 per month for 5 mg and above, provided you refill on schedule. No insurance is involved; you draw each weekly dose with a syringe from a small vial instead of using the auto-injector pen.

The mechanics: your prescriber sends the prescription to LillyDirect, you set up an account, confirm self-pay pricing, and vials ship to your home. The refill-timing condition matters — the discounted price is tied to staying on schedule, so calendar your reorder about a week before you run out. Vial handling is slightly more involved than a pen but is taught in minutes. Full ordering details, the vial-versus-pen tradeoffs, and refill rules live in our LillyDirect vials guide.

The Insurance Route: What Actually Gets Covered

Commercial coverage for Zepbound is genuinely mixed. Plans that cover weight management medication typically require prior authorization documenting BMI, comorbidities, and sometimes prior weight loss attempts; approved patients often pay copays of $25 to $50. But many employer plans exclude the entire weight loss category — an exclusion no appeal can overcome, because it is a plan design choice rather than a clinical judgment.

Two nuances work in your favor. First, the sleep apnea indication: patients prescribed Zepbound for obstructive sleep apnea with obesity are applying under a different, often more accepted, coverage logic — including within Medicare. Second, HSA and FSA funds apply to self-pay fills, softening the LillyDirect price with pre-tax dollars. Practical order of operations: have your prescriber run prior authorization first, and treat LillyDirect as the immediate fallback rather than waiting weeks in limbo.

Documentation quality decides marginal cases. A prior authorization citing a measured BMI, a diagnosed comorbidity with its date, and any previous structured weight loss attempt clears review faster than a bare prescription — and telehealth platforms that handle Zepbound daily tend to submit exactly that package by default. If a denial does arrive, request the reason in writing: category exclusions end the road, but missing-documentation denials are routinely overturned on resubmission.

From Approval to First Dose

Once the prescription exists, the last mile is short. Insurance fills go to retail or mail pharmacies — same day at a counter, two to five business days by mail. LillyDirect vials typically arrive within about a week of account setup. Everything ships or is handed over cold; refrigerate on arrival.

You start at 2.5 mg weekly, a deliberately low on-ramp, and step up roughly every four weeks as tolerated, with provider check-ins gating each increase. Pick a fixed injection day, rotate sites between abdomen, thigh, and upper arm, and keep refills a week ahead of need — dose gaps are the most common self-inflicted setback in the first six months. If cash cost remains the blocker even at LillyDirect pricing, compounded tirzepatide via licensed telehealth runs roughly $199 to $449 per month under the personalized-prescription rules in force since the shortage ended.